TPST - Tempest Therapeutics GAAP EPS of -$2.07 beats by $0.58
2025-08-11 16:45:32 ET
More on Tempest Therapeutics
- Tempest announces $4.6 million registered direct offering of common stock; shares decline over 13%
- Tempest Therapeutics GAAP EPS of -$3.16 misses by $0.01
- Seeking Alpha’s Quant Rating on Tempest Therapeutics
- Historical earnings data for Tempest Therapeutics
- Financial information for Tempest Therapeutics